CEL-SCI Corp (CVM) Misses Q2 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. META
5. SPY
6. INTC
7. ANT
8. AAPL
9. JBLU
10. NVDA

Go back to CEL-SCI Corp (CVM) Misses Q2 EPS by 7c

CEL-SCI Corporation Reports Second Quarter Fiscal Year 2015 Financial Results

May 8, 2015 5:00 PM EDT

VIENNA, Va.--(BUSINESS WIRE)-- CEL-SCI Corporation (NYSE MKT: CVM) today reported financial results for the quarter ended March 31, 2015.

Recent key clinical developments include:

Reported new record high patient enrollment numbers - 24 patients in January, 25 patients in February and 29 patients in March in the Phase III head and neck cancer trial; with continued increase post-Q2 of 31 patients in April A total of four hundred thirty-seven (437) patients have been enrolled in the Phase III study as of April 30, 2015. Trial received clearance in Romania, the... More